Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Omniplex
- Development stage
- Unknown
- Lead developer
- Omnica Laboratories
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Omniplex is an oral vitamin B-complex and vitamin C combination capsule developed and manufactured by Omnica Laboratories in Nepal. It contains a combination of essential water-soluble vitamins, including thiamine (vitamin B1), riboflavin (vitamin B2), nicotinamide (vitamin B3), calcium pantothenate (vitamin B5), pyridoxine (vitamin B6), cyanocobalamin (vitamin B12), and ascorbic acid (vitamin C). Omniplex is indicated for the prevention and treatment of vitamin B and vitamin C deficiencies, as well as associated clinical manifestations such as glossitis, stomatitis, cheilosis, beriberi, and polyneuritis.
- Brand names
- Omniplex
- Other names
- Vitamin B-complex with vitamin C
Beyond the preview
Go deeper on Omniplex.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Omniplex.